PROCEPT BioRobotics (PRCT) Operating Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Operating Expenses data on file, last reported at $86.6 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 20.89% year-over-year to $86.6 million in Q1 2026; TTM through Mar 2026 was $315.0 million, a 24.7% increase from a year earlier, with the FY2025 full-year figure at $300.1 million, up 28.4% from the prior year.
• Operating Expenses for Q1 2026 stood at $86.6 million, up from $77.4 million in the prior quarter.
• Over the last five years, Operating Expenses for PRCT reached as high as $86.6 million in Q1 2026 and fell as low as $23.4 million in Q1 2022.
• Historically, Operating Expenses has averaged $54.0 million across 5 years, with a median of $52.7 million in 2024.
• Across the five-year window, Operating Expenses jumped 89.8% in 2022 and gained 20.89% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $35.7 million in 2022, then surged by 42.27% to $50.8 million in 2023, then climbed by 24.74% to $63.4 million in 2024, then grew by 22.04% to $77.4 million in 2025, then rose by 11.89% to $86.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $86.6 million in Q1 2026, $77.4 million in Q4 2025, and $77.2 million in Q3 2025.